Filing search / Quanterix Corporation / "Access" / Page 3

8-K

EX-99.1

5fik3gmzsduoi1ymae

5 May 21

Quanterix Corporation Releases Operating Results for First Quarter 2021

4:12pm

DEFA14A

751 tfdssgum6a5roo

29 Apr 21

Additional proxy soliciting materials

12:49pm

8-K

EX-99.1

hfg5fe0fmhz3t

28 Apr 21

Quanterix Appoints Laurie Olson to Board of Directors

7:37am

8-K

EX-99.1

n3qerj9zxlvu1

2 Mar 21

Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2020

4:17pm

424B5

ycn1rg 2hndi1tr

4 Feb 21

Prospectus supplement for primary offering

4:54pm

8-K

EX-1.1

arn 1hs091etctfva

4 Feb 21

Quanterix Prices Public Offering of Common Stock

9:07am

424B5

kyhpmi91gr4b1jgc4r

3 Feb 21

Prospectus supplement for primary offering

5:02pm

8-K

EX-99.1

4n9h5nqf5 27

13 Jan 21

Quanterix Provides Operational and Preliminary Financial Highlights

9:17am

S-3ASR

f7uy dfml9

6 Nov 20

Automatic shelf registration

4:16pm

8-K

EX-99.1

m09gjlxq41

5 Nov 20

Results of Operations and Financial Condition

4:18pm

8-K

EX-99.1

peukq genmvi9sl

5 Oct 20

Quanterix Enters into a License Agreement that Grants Abbott Access to Portfolio of Bead-Based Technology Patents for Use in In Vitro Diagnostics

4:30pm

8-K

EX-10.1

ueu5y

5 Oct 20

Quanterix Enters into a License Agreement that Grants Abbott Access to Portfolio of Bead-Based Technology Patents for Use in In Vitro Diagnostics

4:30pm

8-K

EX-1.1

6y7e0fyp9

7 Aug 20

Quanterix Prices Public Offering of Common Stock

5:25pm

424B5

hyis2 qlrw6

7 Aug 20

Prospectus supplement for primary offering

4:23pm

424B5

9j943ko suvkvrtsybk

6 Aug 20

Prospectus supplement for primary offering

4:25pm